# CISATRACURIUM BESYLATE
> **ANDA203079** · Abbreviated New Drug Application (Generic) · Sponsor: HIKMA · Approved 2023-04-19
## Drug
- **FDA Application Number:** ANDA203079
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** CISATRACURIUM BESYLATE
- **Generic name:** CISATRACURIUM BESYLATE
- **Active ingredients:** CISATRACURIUM BESYLATE
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** HIKMA
- **Manufacturer:** Hikma Pharmaceuticals USA Inc.
- **First approval:** 2023-04-19
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203079)
---
*MORVS · CC0 1.0*